These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. PEMBROLIZUMAB-RELATED BILATERAL OCULAR HYPOTONY ASSOCIATED WITH CILIARY DETACHMENTS AND MACULA OEDEMA: A TREATMENT-RESISTANT SIDE EFFECT. Bec L; Khouri C; Chiquet C Retin Cases Brief Rep; 2024 Mar; ():. PubMed ID: 38452261 [TBL] [Abstract][Full Text] [Related]
4. Vision loss with pembrolizumab treatment: A report of two cases. Telfah M; Whittaker TJ; C Doolittle G J Oncol Pharm Pract; 2019 Sep; 25(6):1540-1546. PubMed ID: 30997872 [TBL] [Abstract][Full Text] [Related]
5. Management of Chronic Hypotony Following Bilateral Uveitis in a Patient Treated with Pembrolizumab for Cutaneous Metastatic Melanoma. Reid G; Lorigan P; Heimann H; Hovan M Ocul Immunol Inflamm; 2019; 27(6):1012-1015. PubMed ID: 29672247 [No Abstract] [Full Text] [Related]
6. Autoimmune Encephalitis following Checkpoint Inhibitor Therapy in a Patient with Metastatic Melanoma in Complete Remission. Civardi G; Medioli A; Braghieri C; Ambroggi M; Immovilli P; Orsucci S; Contini P; Aronica G; Cavanna L Medicina (Kaunas); 2024 Apr; 60(5):. PubMed ID: 38792910 [TBL] [Abstract][Full Text] [Related]
7. Inflammatory Arthritis Induced by Pembrolizumab in a Patient With Head and Neck Squamous Cell Carcinoma. Spathas N; Economopoulou P; Cheila M; Kotsantis I; Fanouriakis A; Kassara D; Psyrri A Front Oncol; 2018; 8():409. PubMed ID: 30319973 [No Abstract] [Full Text] [Related]
8. A Rare Case of Pembrolizumab-Induced Uveitis in a Patient with Metastatic Melanoma. Hanna KS Pharmacotherapy; 2016 Nov; 36(11):e183-e188. PubMed ID: 27716999 [TBL] [Abstract][Full Text] [Related]
9. Standard-dose pembrolizumab in combination with reduced-dose ipilimumab for patients with advanced melanoma (KEYNOTE-029): an open-label, phase 1b trial. Long GV; Atkinson V; Cebon JS; Jameson MB; Fitzharris BM; McNeil CM; Hill AG; Ribas A; Atkins MB; Thompson JA; Hwu WJ; Hodi FS; Menzies AM; Guminski AD; Kefford R; Kong BY; Tamjid B; Srivastava A; Lomax AJ; Islam M; Shu X; Ebbinghaus S; Ibrahim N; Carlino MS Lancet Oncol; 2017 Sep; 18(9):1202-1210. PubMed ID: 28729151 [TBL] [Abstract][Full Text] [Related]
10. Immune checkpoint inhibitor-associated arthritis in advanced pulmonary adenocarcinoma: A case report. Yang Y; Huang XJ World J Clin Cases; 2022 Oct; 10(29):10701-10707. PubMed ID: 36312471 [TBL] [Abstract][Full Text] [Related]
11. Case Report: Serial changes of ocular complications related to immune checkpoint inhibitors pembrolizumab and nivolumab. Cho WH; Chiang WY Front Ophthalmol (Lausanne); 2022; 2():1021574. PubMed ID: 38983552 [TBL] [Abstract][Full Text] [Related]
12. Autoimmune inner ear disease in a melanoma patient treated with pembrolizumab. Zibelman M; Pollak N; Olszanski AJ J Immunother Cancer; 2016; 4():8. PubMed ID: 26885370 [TBL] [Abstract][Full Text] [Related]
13. Immune checkpoint blocker-related sarcoid-like granulomatous inflammation: a rare adverse event detected in lymph node aspiration cytology of patients treated for advanced malignant melanoma. Rodriguez EF; Lipson E; Suresh K; Cappelli LC; Monaco SE; Maleki Z Hum Pathol; 2019 Sep; 91():69-76. PubMed ID: 31279873 [TBL] [Abstract][Full Text] [Related]
14. When Uveitis and Hypotony Meets Bilateral Iris Retraction Syndrome: A Rare but Serious Complication of Nivolumab Treatment. Kandarakis SA; Doumazos L; Karageorgiou G; Petrou P; Doumazos S; Malamos P; Georgalas I Case Rep Ophthalmol; 2024; 15(1):552-558. PubMed ID: 39015242 [TBL] [Abstract][Full Text] [Related]
16. Pembrolizumab-induced autoimmune encephalitis in a patient with advanced non-small cell lung cancer: A case report. Niki M; Nakaya A; Kurata T; Nakahama K; Yoshioka H; Kaneda T; Kibata K; Ogata M; Nomura S Mol Clin Oncol; 2019 Feb; 10(2):267-269. PubMed ID: 30680206 [TBL] [Abstract][Full Text] [Related]
17. Safety of pembrolizumab for the treatment of melanoma. Martin-Liberal J; Kordbacheh T; Larkin J Expert Opin Drug Saf; 2015 Jun; 14(6):957-64. PubMed ID: 25927979 [TBL] [Abstract][Full Text] [Related]
18. A CASE OF ACQUIRED GENERALIZED LIPODYSTROPHY ASSOCIATED WITH PEMBROLIZUMAB IN A PATIENT WITH METASTATIC MALIGNANT MELANOMA. Bedrose S; Turin CG; Lavis VR; Kim ST; Thosani SN AACE Clin Case Rep; 2020; 6(1):e40-e45. PubMed ID: 32524008 [TBL] [Abstract][Full Text] [Related]
19. Activated pulmonary tuberculosis in a patient with melanoma during PD-1 inhibition: a case report. He W; Zhang X; Li W; Kong C; Wang Y; Zhu L; Xu R; Deng G; Zhang P Onco Targets Ther; 2018; 11():7423-7427. PubMed ID: 30425530 [TBL] [Abstract][Full Text] [Related]
20. Pembrolizumab-related systemic myositis involving ocular and hindneck muscles resembling myasthenic gravis: a case report. Kamo H; Hatano T; Kanai K; Aoki N; Kamiyama D; Yokoyama K; Takanashi M; Yamashita Y; Shimo Y; Hattori N BMC Neurol; 2019 Aug; 19(1):184. PubMed ID: 31382909 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]